A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Public ClinicalTrials.gov record NCT07053423. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Dupilumab on Airway Inflammation Through Assessments of Mucus Plugging and Other Lung Imaging Parameters in Patients With Chronic Obstructive Pulmonary Disease.
Study identification
- NCT ID
- NCT07053423
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 218 participants
Conditions and interventions
Conditions
Interventions
- Dupilumab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 21, 2025
- Primary completion
- Dec 22, 2028
- Completion
- Feb 1, 2029
- Last update posted
- May 19, 2026
2025 – 2029
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham - School of Medicine- Site Number : 8400003 | Birmingham | Alabama | 35233 | Recruiting |
| Finlay Medical Research- Site Number : 8400010 | Miami | Florida | 33126 | Recruiting |
| Private Practice - Dr. David Kavtaradze- Site Number : 8400017 | Cordele | Georgia | 31015 | Recruiting |
| Johns Hopkins Bayview Medical Center- Site Number : 8400009 | Baltimore | Maryland | 21224 | Recruiting |
| Brigham & Women's Hospital- Site Number : 8400014 | Boston | Massachusetts | 02115 | Recruiting |
| American Health Research - Charlotte- Site Number : 8400013 | Charlotte | North Carolina | 28277 | Recruiting |
| Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004 | Winston-Salem | North Carolina | 27103 | Recruiting |
| Clinical Research Associates of Central Pennsylvania- Site Number : 8400002 | DuBois | Pennsylvania | 15801 | Recruiting |
| REX Clinical Trials - Beaumont- Site Number : 8400011 | Beaumont | Texas | 77701 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07053423, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 19, 2026 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07053423 live on ClinicalTrials.gov.